DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 124 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $512,540 | -45.1% | 36,402 | -39.8% | 0.01% | -50.0% |
Q1 2023 | $934,262 | +149.8% | 60,470 | +165.0% | 0.03% | +136.4% |
Q4 2022 | $373,938 | -35.1% | 22,815 | -26.7% | 0.01% | -45.0% |
Q3 2022 | $576,000 | +311.4% | 31,138 | +117.8% | 0.02% | +122.2% |
Q4 2021 | $140,000 | -88.5% | 14,299 | -51.7% | 0.01% | -89.9% |
Q1 2020 | $1,220,000 | +141.1% | 29,634 | +264.5% | 0.09% | +196.7% |
Q4 2019 | $506,000 | +96.1% | 8,131 | +7.1% | 0.03% | +36.4% |
Q3 2019 | $258,000 | -37.2% | 7,593 | -57.1% | 0.02% | -24.1% |
Q1 2019 | $411,000 | +102.5% | 17,708 | +243.6% | 0.03% | +107.1% |
Q2 2018 | $203,000 | – | 5,153 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 2,086,723 | $85,910,000 | 25.70% |
SV Health Investors, LLC | 449,951 | $18,525,000 | 15.54% |
Redmile Group, LLC | 5,116,263 | $210,637,000 | 5.90% |
Eversept Partners, LP | 414,081 | $17,047,715 | 4.24% |
Sunesis Advisors, LLC | 96,299 | $3,965,000 | 3.99% |
Avoro Capital Advisors LLC | 2,000,000 | $82,340,000 | 2.78% |
Opaleye Management Inc. | 222,000 | $9,140,000 | 2.42% |
SECTORAL ASSET MANAGEMENT INC | 204,059 | $8,401,000 | 1.61% |
Artal Group S.A. | 800,000 | $32,936,000 | 1.39% |
Atika Capital Management LLC | 141,000 | $5,805,000 | 1.11% |